29 insiders have filed at MRVI since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Maravai Life Sciences Holdings, Llc | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Maravai Life Sciences Holdings 2, Llc | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Co-Invest Xi Lp | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Fund Xi/B Lp | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Fund Xi/C Lp | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Partners Xi/B Lp | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Investment Xi Llc | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Gtcr Partners Xi/A&c Lp | Director | 130.83M | 89.352% | 1 sells $97.6M | |
| Brust Bernd | Chief Executive Officer | 2.47M | 1.685% | 3 buys $1.5M | |
| Martin William E. III | Chief Executive Officer | 1.81M | 1.239% | ||
| Leddy Peter Michael | See Remarks | 727.2k | 0.497% | ||
| Herde Kevin | Chief Financial Officer | 674.6k | 0.461% | ||
| Asarpota Rajesh | Chief Financial Officer | 500.0k | 0.341% | ||
| Hull Carl | See Remarks | 477.1k | 0.326% | 1 buys $987k | |
| Dolan Christine | See Remarks | 420.3k | 0.287% | ||
| Oreshack Kurt | General Counsel | 385.0k | 0.263% | 1 sells $126k | |
| Burch Andrew | See Remarks | 369.2k | 0.252% | ||
| Eckert R Andrew | Director | 365.9k | 0.25% | ||
| Buzzeo Rebecca | See Remarks | 310.9k | 0.212% | ||
| Lucier Gregory T | Director | 264.9k | 0.181% | 2 buys $369k | |
| Hopfield Jessica | Director | 199.9k | 0.137% | ||
| Gray Susannah | Director | 169.9k | 0.116% | ||
| Deford John A | Director | 159.2k | 0.109% | 1 buys $101k | |
| Prahalad Murali | Director | 154.6k | 0.106% | ||
| Cunningham Sean Laurence | Director | 138.1k | 0.094% | ||
| Mihas Constantine S | Director | 138.1k | 0.094% | ||
| Marker Luke Joseph | Director | 138.1k | 0.094% | ||
| Daverman Benjamin James | Director | 138.1k | 0.094% | ||
| Ashkenazi Anat | Director | 60.8k | 0.042% |
Full register at boothcheck.com/insiders/MRVI. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.